Two Sigma Investments, LP Lixte Biotechnology Holdings, Inc. Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.51 - $1.89 $2,563 - $9,501
5,027 Added 25.29%
24,901 $20,000
Q4 2022

Feb 14, 2023
SELL
$0.48 - $6.0 $672 - $8,400
-1,400 Reduced 6.58%
19,874 $10,000
Q3 2022

Nov 14, 2022
BUY
$0.12 - $5.9 $519 - $25,523
4,326 Added 25.53%
21,274 $12,000
Q2 2022

Aug 15, 2022
BUY
$0.12 - $0.35 $2,033 - $5,931
16,948 New
16,948 $13,000

About LIXTE BIOTECHNOLOGY HOLDINGS, INC.

LIXT Quotes by TradingView
  • Ticker LIXT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,646,600
  • Market Cap $33M
  • Description
  • Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agent...
More about LIXT
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email